CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

The Lancet
Original article

[Comment] Stopping β-blockers long after myocardial infarction

β-blockersNeutral
AI Analysis

Summary

Editorial comment discussing the evolution of β-blocker use after myocardial infarction, noting that long-standing practice based on 1980s trials may need reconsideration in light of modern reperfusion and medical therapies.

Importance:2/10
Sentiment:
0.00
cardiovascularmyocardial infarctionpharmacotherapybeta-blockerscommentary

Read the original article

Published by The Lancet on August 30, 2026 7:30 AM

Read Original